Review Article
Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes
Table 1
Therapeutic candidates against diabetic cardiovascular complications.
| Category | Examples | Mechanisms of act |
| Traditional hypoglycemic agents | Metformin | Antioxidant properties and possible effects on the reduction of AGE |
| Antioxidants | Vitamin C and vitamin E | Antioxidant properties | ACEIs and ARBs | Reduce angiotensin II-induced oxidative stress | Statins | Reduce lipid peroxidation |
| AGE-RAGE inhibitors | ALT-711 | AGE cross-link breaker | Aminoguanidine | Inhibit AGE formation | Soluble RAGE | Competitively combine with AGEs |
| New hypoglycemic agents | GLP-1 receptor agonists | Not fully understood | DDP-4 inhibitors | Not fully understood | SGLT-2 inhibitors | Not fully understood |
|
|